WO2003106461A3 - Formes pseudopolymorphiques de l'inhibiteur de la protease du vih - Google Patents
Formes pseudopolymorphiques de l'inhibiteur de la protease du vih Download PDFInfo
- Publication number
- WO2003106461A3 WO2003106461A3 PCT/EP2003/050176 EP0350176W WO03106461A3 WO 2003106461 A3 WO2003106461 A3 WO 2003106461A3 EP 0350176 W EP0350176 W EP 0350176W WO 03106461 A3 WO03106461 A3 WO 03106461A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease inhibitor
- hiv protease
- pseudopolymorphic forms
- forms
- pseudopolymorphic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16158480.0A EP3045460B1 (fr) | 2002-05-16 | 2003-05-16 | Formes pseudopolymorphiques d'un inhibiteur de la protéase du vih |
BRPI0311176A BRPI0311176B8 (pt) | 2002-05-16 | 2003-05-16 | pseudopolimorfo na forma de etanolato, seu uso, processo de preparação do mesmo e composição farmacêutica |
AP2004003191A AP2052A (en) | 2002-05-16 | 2003-05-16 | Pseudopolymorphic forms of HIV protease inhibitor |
EP10180831.9A EP2314591B2 (fr) | 2002-05-16 | 2003-05-16 | Formes pseudopolymorphiques de l'inhibiteur de la protease du VIH |
AU2003271740A AU2003271740B2 (en) | 2002-05-16 | 2003-05-16 | Pseudopolymorphic forms of a HIV protease inhibitor |
MXPA04011427A MXPA04011427A (es) | 2002-05-16 | 2003-05-16 | Formas seudopolimorficas de un inhibidor de proteasa del virus de inmunodeficiencia adquirida. |
EA200401503A EA007120B8 (ru) | 2002-05-16 | 2003-05-16 | Псевдополиморфные формы ингибитора вич-протеазы |
US10/514,352 US7700645B2 (en) | 2002-05-16 | 2003-05-16 | Pseudopolymorphic forms of a HIV protease inhibitor |
CA002485834A CA2485834C (fr) | 2002-05-16 | 2003-05-16 | Formes pseudopolymorphiques de l'inhibiteur de la protease du vih |
JP2004513292A JP4864320B2 (ja) | 2002-05-16 | 2003-05-16 | Hivプロテアーゼ阻害剤の疑似多形相 |
DK03753571.3T DK1567529T4 (da) | 2002-05-16 | 2003-05-16 | Pseudopolymorfe former af en hiv-proteaseinhibitor |
EP03753571.3A EP1567529B2 (fr) | 2002-05-16 | 2003-05-16 | Formes pseudopolymorphiques de l'inhibiteur de la protease du vih |
KR1020047018426A KR101128370B1 (ko) | 2002-05-16 | 2003-05-16 | Hiv 프로테아제 저해제의 유사다형체 |
NZ536497A NZ536497A (en) | 2002-05-16 | 2003-05-16 | Pseudopolymorphic forms of a HIV protease inhibitor and their use as a medicament |
SI200332389T SI1567529T2 (sl) | 2002-05-16 | 2003-05-16 | Psevdopolimorfne oblike zaviralca HIV proteaze |
ES03753571T ES2498370T5 (es) | 2002-05-16 | 2003-05-16 | Formas pseudopolimórficas de un inhibidor de la proteasa de VIH |
IL16514004A IL165140A0 (en) | 2002-05-16 | 2004-11-10 | Pseudopolymorphic forms of a hiv protease inhibitor |
HRP20041061AA HRP20041061B1 (hr) | 2002-05-16 | 2004-11-12 | Pseudopolimorfni oblici inhibitora hiv proteaze |
NO20045409A NO331477B1 (no) | 2002-05-16 | 2004-12-10 | Etanolat pseudopolymorfe former av en HIV-proteaseinhibitor, fremgangsmate ved fremstilling derav samt anvendelse derav |
ZA2004/10154A ZA200410154B (en) | 2002-05-16 | 2004-12-15 | Pseudopolymorphic forms of a hiv protease inhibitor |
HK06102443.3A HK1081969A1 (en) | 2002-05-16 | 2006-02-23 | Pseudopolymorphic forms of a hiv protease inhibitor hiv |
US12/536,807 US8518987B2 (en) | 2002-05-16 | 2009-08-06 | Pseudopolymorphic forms of a HIV protease inhibitor |
US13/939,494 US20130303790A1 (en) | 2002-05-16 | 2013-07-11 | Pseudopolymorphic Forms Of A HIV Protease Inhibitor |
US14/183,712 US20140171499A1 (en) | 2002-05-16 | 2014-02-19 | Pseudopolymorphic Forms Of A HIV Protease Inhibitor |
CY20141100756T CY1117928T1 (el) | 2002-05-16 | 2014-09-17 | Ψευδοπολυμορφικες μορφες ενος αναστολεα πρωτεασης hiv |
US14/817,827 US20150336980A1 (en) | 2002-05-16 | 2015-08-04 | Pseudopolymorphic Forms Of A HIV Protease Inhibitor |
US15/600,932 US10000504B2 (en) | 2002-05-16 | 2017-05-22 | Pseudopolymorphic forms of a HIV protease inhibitor |
US15/980,993 US10858369B2 (en) | 2002-05-16 | 2018-05-16 | Pseudopolymorphic forms of a HIV protease inhibitor |
US17/085,096 US20210179631A1 (en) | 2002-05-16 | 2020-10-30 | Pseudopolymorphic Forms of a HIV Protease Inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02076929 | 2002-05-16 | ||
EP02076929.5 | 2002-05-16 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10514352 A-371-Of-International | 2003-05-16 | ||
US10/514,352 A-371-Of-International US7700645B2 (en) | 2002-05-16 | 2003-05-16 | Pseudopolymorphic forms of a HIV protease inhibitor |
US12/536,807 Division US8518987B2 (en) | 2002-05-16 | 2009-08-06 | Pseudopolymorphic forms of a HIV protease inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003106461A2 WO2003106461A2 (fr) | 2003-12-24 |
WO2003106461A3 true WO2003106461A3 (fr) | 2004-05-13 |
Family
ID=29724454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/050176 WO2003106461A2 (fr) | 2002-05-16 | 2003-05-16 | Formes pseudopolymorphiques de l'inhibiteur de la protease du vih |
Country Status (26)
Country | Link |
---|---|
US (8) | US7700645B2 (fr) |
EP (4) | EP2314591B2 (fr) |
JP (1) | JP4864320B2 (fr) |
KR (2) | KR101128370B1 (fr) |
CN (1) | CN100475819C (fr) |
AP (1) | AP2052A (fr) |
AU (2) | AU2003271740B2 (fr) |
BR (1) | BRPI0311176B8 (fr) |
CA (1) | CA2485834C (fr) |
CY (3) | CY1117928T1 (fr) |
DK (3) | DK1567529T4 (fr) |
EA (1) | EA007120B8 (fr) |
ES (4) | ES2498370T5 (fr) |
HK (1) | HK1081969A1 (fr) |
HR (1) | HRP20041061B1 (fr) |
HU (1) | HUE034389T2 (fr) |
IL (1) | IL165140A0 (fr) |
LT (1) | LT2767539T (fr) |
MX (1) | MXPA04011427A (fr) |
NO (1) | NO331477B1 (fr) |
NZ (1) | NZ536497A (fr) |
PL (1) | PL215151B1 (fr) |
PT (3) | PT1567529E (fr) |
SI (3) | SI1567529T2 (fr) |
WO (1) | WO2003106461A2 (fr) |
ZA (1) | ZA200410154B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1088098E (pt) | 1998-06-23 | 2011-05-25 | Univ Illinois | Medicamento para tratar mam?feros infectados com hiv |
EA007120B8 (ru) | 2002-05-16 | 2012-03-30 | Тиботек Фармасьютикалз Лтд. | Псевдополиморфные формы ингибитора вич-протеазы |
HRP20020614A2 (en) * | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
JP4818124B2 (ja) | 2003-12-23 | 2011-11-16 | テイボテク・フアーマシユーチカルズ・リミテツド | (3R,3aS,6aR)−ヘキサヒドロフロ〔2,3−b〕フラン−3−イル(1S,1R)−3−〔〔(4−アミノフェニル)スルホニル〕(イソブチル)アミノ〕−1−ベンジル−2−ヒドロキシプロピルカルバマートの製造方法 |
KR101333627B1 (ko) | 2005-02-25 | 2013-11-27 | 얀센 알 앤드 디 아일랜드 | 프로테아제 저해제 전구체 합성 |
WO2008055970A2 (fr) * | 2006-11-09 | 2008-05-15 | Tibotec Pharmaceuticals Ltd. | Procédés pour la préparation du hexahydrofuro[2,3-b]furan-3-ol |
AR073248A1 (es) | 2008-09-01 | 2010-10-20 | Tibotec Pharm Ltd | Proceso para la preparacion de (1s, 2r)-3- ((4-aminofenil) sulfonil) ( isobutil) amino)-1- bencil-2- hidroxipropilcarbamato de (3r, 3as,6ar)- hexahidrofuro-(2,3-b) furan-3- ilo (darunavir) y compuestos intermediarios utiles en dicho proceso. |
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
MX2011007790A (es) * | 2009-01-29 | 2011-11-18 | Mapi Pharma Ltd | Polimorfos de darunavir. |
US8703980B2 (en) * | 2009-09-17 | 2014-04-22 | Siva Rama Prasad Vellanki | Process for the preparation of darunavir |
BR112012009956A2 (pt) | 2009-10-30 | 2015-09-29 | Lupin Ltd | um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula. |
PT2513116E (pt) * | 2009-12-16 | 2015-10-14 | Hetero Research Foundation | Polimorfos de darunavir |
WO2011083287A2 (fr) * | 2010-01-05 | 2011-07-14 | Cipla Limited | Polymorphe de darunavir et son procédé de préparation |
JP2013518096A (ja) | 2010-01-28 | 2013-05-20 | マピ ファーマ リミテッド | ダルナビル及びダルナビル中間体の調製方法 |
WO2011145099A1 (fr) * | 2010-05-20 | 2011-11-24 | Hetero Research Foundation | Sel de chlorhydrate cristallin de darunavir |
WO2012107889A1 (fr) | 2011-02-10 | 2012-08-16 | Ranbaxy Laboratories Limited | Procédé destiné à la préparation de darunavir amorphe |
JP6122427B2 (ja) | 2011-07-07 | 2017-04-26 | ヤンセン・サイエンシズ・アイルランド・ユーシー | ダルナビル複合製剤 |
WO2013114382A1 (fr) | 2011-12-05 | 2013-08-08 | Mylan Laboratories Ltd | Darunavir cristallin |
EP2804869B1 (fr) * | 2012-01-18 | 2019-06-12 | Aurobindo Pharma Limited | Nouveaux solvates de darunavir |
CN103509031B (zh) * | 2012-06-20 | 2016-04-27 | 上海迪赛诺药业有限公司 | 制备达芦那韦无定形物的方法 |
US9475821B2 (en) * | 2012-07-24 | 2016-10-25 | Laurus Labs Private Limited | Process for preparation of Darunavir |
US9227990B2 (en) | 2012-10-29 | 2016-01-05 | Cipla Limited | Antiviral phosphonate analogues and process for preparation thereof |
US9346820B2 (en) * | 2013-09-11 | 2016-05-24 | Purdue Research Foundation | HIV-1 protease inhibitors having gem-di-fluoro bicyclic P2-ligands |
WO2016092525A1 (fr) * | 2014-12-12 | 2016-06-16 | Lupin Limited | Darunavir n-propanol solvate et son procédé de préparation |
WO2016092527A1 (fr) * | 2014-12-12 | 2016-06-16 | Sun Pharmaceutical Industries Limited | Procédé de préparation de dolutégravir |
WO2016149486A1 (fr) | 2015-03-19 | 2016-09-22 | Viamet Pharmaceuticals, Inc. | Composés antifongiques et procédés de fabrication |
EP3496719B1 (fr) | 2016-08-08 | 2023-06-14 | Hetero Labs Limited | Composition antirétrovirale multi-classe |
BR112019002132A2 (pt) | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composições anti-retrovirais |
US10407438B2 (en) | 2016-10-27 | 2019-09-10 | Gilead Sciences, Inc. | Crystalline forms of darunavir |
CN108727401A (zh) * | 2017-04-20 | 2018-11-02 | 盐城迪赛诺制药有限公司 | 达鲁那韦新晶型及其制备方法和应用 |
CN109053753A (zh) * | 2018-08-05 | 2018-12-21 | 浙江大学 | 一种制备达卢那韦二水合物晶型的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006030A1 (fr) * | 1993-08-24 | 1995-03-02 | G.D. Searle & Co. | Hydroxyethylamino-sulfonamides aptes a etre utilises comme inhibiteurs de protease retrovirale |
WO1999067417A2 (fr) * | 1998-06-23 | 1999-12-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Analyse de potentiel biochimique et methodes associees |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
JPH05230044A (ja) | 1992-02-21 | 1993-09-07 | Hoechst Japan Ltd | ピレタニドの新規な結晶多形 |
US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
ES2150105T3 (es) | 1995-02-22 | 2000-11-16 | Aventis Pharma Ltd | Piretanida amorfa, polimorfos de piretanida, proceso para su preparacion y su uso. |
ZA984514B (en) | 1997-05-29 | 1998-11-30 | Merck & Co Inc | Hiv protease inhibitor |
GB9712253D0 (en) | 1997-06-13 | 1997-08-13 | Glaxo Group Ltd | Antiviral compound |
US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
GB9805898D0 (en) | 1998-03-20 | 1998-05-13 | Glaxo Group Ltd | Process for the sythesis of hiv protease inhibitors |
GB9807354D0 (en) | 1998-04-07 | 1998-06-03 | Glaxo Group Ltd | Antiviral compound |
AU4828199A (en) * | 1998-06-23 | 2000-01-10 | Board Of Trustees Of The University Of Illinois, The | Multi-drug resistant retroviral protease inhibitors and associated methods |
EP1131303A1 (fr) | 1998-11-19 | 2001-09-12 | Du Pont Pharmaceuticals Company | (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1h)-quinazolinone cristalline |
EP1159278B1 (fr) | 1999-02-12 | 2005-11-30 | Vertex Pharmaceuticals Incorporated | Inhibiteurs d'aspartyle protease |
EA007120B8 (ru) | 2002-05-16 | 2012-03-30 | Тиботек Фармасьютикалз Лтд. | Псевдополиморфные формы ингибитора вич-протеазы |
WO2011083287A2 (fr) * | 2010-01-05 | 2011-07-14 | Cipla Limited | Polymorphe de darunavir et son procédé de préparation |
-
2003
- 2003-05-16 EA EA200401503A patent/EA007120B8/ru unknown
- 2003-05-16 PT PT37535713T patent/PT1567529E/pt unknown
- 2003-05-16 AP AP2004003191A patent/AP2052A/xx active
- 2003-05-16 CN CNB038164590A patent/CN100475819C/zh not_active Expired - Lifetime
- 2003-05-16 SI SI200332389T patent/SI1567529T2/sl unknown
- 2003-05-16 PT PT141686865T patent/PT2767539T/pt unknown
- 2003-05-16 PT PT101808319T patent/PT2314591E/pt unknown
- 2003-05-16 EP EP10180831.9A patent/EP2314591B2/fr not_active Expired - Lifetime
- 2003-05-16 EP EP03753571.3A patent/EP1567529B2/fr not_active Expired - Lifetime
- 2003-05-16 ES ES03753571T patent/ES2498370T5/es not_active Expired - Lifetime
- 2003-05-16 EP EP16158480.0A patent/EP3045460B1/fr not_active Expired - Lifetime
- 2003-05-16 KR KR1020047018426A patent/KR101128370B1/ko active IP Right Grant
- 2003-05-16 KR KR1020107024106A patent/KR20100119906A/ko not_active Application Discontinuation
- 2003-05-16 AU AU2003271740A patent/AU2003271740B2/en not_active Revoked
- 2003-05-16 SI SI200332383T patent/SI2314591T2/sl unknown
- 2003-05-16 JP JP2004513292A patent/JP4864320B2/ja not_active Expired - Lifetime
- 2003-05-16 NZ NZ536497A patent/NZ536497A/en not_active IP Right Cessation
- 2003-05-16 ES ES14168686.5T patent/ES2638412T3/es not_active Expired - Lifetime
- 2003-05-16 ES ES10180831T patent/ES2503551T5/es not_active Expired - Lifetime
- 2003-05-16 DK DK03753571.3T patent/DK1567529T4/da active
- 2003-05-16 MX MXPA04011427A patent/MXPA04011427A/es active IP Right Grant
- 2003-05-16 DK DK10180831.9T patent/DK2314591T4/da active
- 2003-05-16 US US10/514,352 patent/US7700645B2/en active Active
- 2003-05-16 HU HUE14168686A patent/HUE034389T2/en unknown
- 2003-05-16 LT LTEP14168686.5T patent/LT2767539T/lt unknown
- 2003-05-16 CA CA002485834A patent/CA2485834C/fr not_active Expired - Lifetime
- 2003-05-16 SI SI200332545T patent/SI2767539T1/sl unknown
- 2003-05-16 ES ES16158480T patent/ES2728735T3/es not_active Expired - Lifetime
- 2003-05-16 EP EP14168686.5A patent/EP2767539B1/fr not_active Expired - Lifetime
- 2003-05-16 PL PL374321A patent/PL215151B1/pl unknown
- 2003-05-16 DK DK14168686.5T patent/DK2767539T3/en active
- 2003-05-16 BR BRPI0311176A patent/BRPI0311176B8/pt active IP Right Grant
- 2003-05-16 WO PCT/EP2003/050176 patent/WO2003106461A2/fr active Application Filing
-
2004
- 2004-11-10 IL IL16514004A patent/IL165140A0/xx unknown
- 2004-11-12 HR HRP20041061AA patent/HRP20041061B1/hr not_active IP Right Cessation
- 2004-12-10 NO NO20045409A patent/NO331477B1/no not_active IP Right Cessation
- 2004-12-15 ZA ZA2004/10154A patent/ZA200410154B/en unknown
-
2006
- 2006-02-23 HK HK06102443.3A patent/HK1081969A1/xx not_active IP Right Cessation
-
2009
- 2009-08-06 US US12/536,807 patent/US8518987B2/en not_active Expired - Lifetime
-
2012
- 2012-07-03 AU AU2012205289A patent/AU2012205289A1/en active Pending
-
2013
- 2013-07-11 US US13/939,494 patent/US20130303790A1/en not_active Abandoned
-
2014
- 2014-02-19 US US14/183,712 patent/US20140171499A1/en not_active Abandoned
- 2014-09-17 CY CY20141100756T patent/CY1117928T1/el unknown
- 2014-09-17 CY CY20141100755T patent/CY1115665T1/el unknown
-
2015
- 2015-08-04 US US14/817,827 patent/US20150336980A1/en not_active Abandoned
-
2017
- 2017-05-22 US US15/600,932 patent/US10000504B2/en not_active Expired - Lifetime
- 2017-08-23 CY CY20171100896T patent/CY1119311T1/el unknown
-
2018
- 2018-05-16 US US15/980,993 patent/US10858369B2/en not_active Expired - Lifetime
-
2020
- 2020-10-30 US US17/085,096 patent/US20210179631A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006030A1 (fr) * | 1993-08-24 | 1995-03-02 | G.D. Searle & Co. | Hydroxyethylamino-sulfonamides aptes a etre utilises comme inhibiteurs de protease retrovirale |
WO1999067417A2 (fr) * | 1998-06-23 | 1999-12-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Analyse de potentiel biochimique et methodes associees |
Non-Patent Citations (4)
Title |
---|
BORKA L ET AL: "Crystal polymorphism of pharmaceuticals", ACTA PHARMACEUTICA JUGOSLAVICA, SAVEZ FARMACEUTSKIH DRUSTAVA JUGOSLAVIJE, ZAGREB, YU, vol. 40, 1990, pages 71 - 94, XP002195530, ISSN: 0001-6667 * |
GHOSH A K ET AL: "Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 8, no. 6, 17 March 1998 (1998-03-17), pages 687 - 690, XP004136945, ISSN: 0960-894X * |
GIRON ET AL: "Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvates", THERMOCHIMICA ACTA, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 248, 1995, pages 1 - 59, XP002101808, ISSN: 0040-6031 * |
GRUNENBERG A ET AL: "THEORETICAL DERIVATION AND PRACTICAL APPLICATION OF ENERGY/TEMPERATURE DIAGRAMS AS AN INSTRUMENT IN PREFORMULATION STUDIES OF POLYMORPHIC DRUG SUBSTANCES", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, vol. 129, 1996, pages 147 - 158, XP000909867, ISSN: 0378-5173 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA007120B8 (ru) | Псевдополиморфные формы ингибитора вич-протеазы | |
IL174960A0 (en) | Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate | |
ME01059B (fr) | Procede pour preparer du (3r,3as,6ar)-hexahydrofuro [2,3-b] furane-3-yle (1s,2r)-3-[[(4-aminophenyle) sulfonyle] (isobutyle) amino]-1-benzyle-2-hydroxypropylcarbamate | |
NO20064977L (no) | Fremgangsmater for fremstilling av (3R,3aS,6aR)-heksahydro-furo[2,3-b]furan-3-ol | |
WO2007047923A3 (fr) | Casque sur mesure et procede de fabrication de ce casque | |
IL198270A0 (en) | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol | |
HRP20040320B1 (hr) | POSTUPAK ZA PRIPRAVU HEKSAHIDRO-FURO[2,3-b]FURAN-3-OLA | |
AU2003287038A8 (en) | Method of preparing (3r, 3as, 6ar) -3- hydroxyhexahydrofuro (2, 3-b) furan and related compounds | |
AU2003219662A1 (en) | 4-OXO-4, 7-DIHYDROFURO(2,3-b)PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS | |
IL185920A0 (en) | A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate | |
MXPA05006089A (es) | Respiradero anular de moldes para superficie de rodadura de neumaticos. | |
WO2004030581A3 (fr) | Endoprothese pour articulation de l'epaule | |
PL368122A1 (en) | A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 536497 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20041061A Country of ref document: HR Ref document number: 2485834 Country of ref document: CA Ref document number: 10514352 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020047018426 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 374321 Country of ref document: PL Ref document number: 2003271740 Country of ref document: AU Ref document number: 2004513292 Country of ref document: JP Ref document number: PA/A/2004/011427 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3598/DELNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003753571 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2004-501839 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004/10154 Country of ref document: ZA Ref document number: 200410154 Country of ref document: ZA Ref document number: 200401503 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038164590 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020047018426 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003753571 Country of ref document: EP |